Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
GI Innovation, Inc.
Eli Lilly and Company
PMV Pharmaceuticals, Inc
Mayo Clinic
Eikon Therapeutics
Tizona Therapeutics, Inc
Essen Biotech
Sairopa B.V.
M.D. Anderson Cancer Center
NuCana plc
Carisma Therapeutics Inc
NextCure, Inc.
Salubris Biotherapeutics Inc
Pliant Therapeutics, Inc.
Eli Lilly and Company
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Rutgers, The State University of New Jersey